P选择素糖蛋白配体1抗体,Anti-PSGL-1/CD162厂家直销,质量稳定、价格可靠,全国免费运输。 上海沪峥专业供应各类一抗、二抗、标记二抗、抗原等多种抗体产品,主要用于石蜡切片免疫组化,冰冻切片免疫组化,Elisa,WB,免疫荧光等科研实验领域,抗体的相关标记:HRP,Biotin,Gold,RBITC,AP,FITC,Cy3,Cy5,Cy5.5,Cy7,PE,PE-...
Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL- 1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising ...
成立时间:2004-10-22企业经济性质:股份有限公司年营业额:1亿-10亿 经营模式:代理商,生产商,员工人数:101-500注册资金:8666.6668万人民币 公司评价 暂时还没有评价我要评价 该公司其他产品 Rabbit IgG nanobody, Rabbit IgG nanobodies价格:价格电议产品详情:温馨提示:优宁维所有产品和服务仅用于科学研究,不用于临床...
所在地:其它 产品型号:Anti-PSGL-1/CD162 简单介绍:P选择素糖蛋白配体1抗体价格查询,P选择素糖蛋白配体1抗体现货供应!别名:Anti-PSGL-1/CD162 CD 162; CD162 antigen; P selectin glycoprotein ligand 1; P selectin glycoprotein ligand 1 。专业抗体产品生产和代理销售商,田源商标!相关...
Anti-PSGL-1 Clone KPL-1 (Mouse Monoclonal)会员价请登录市场价￥3381原厂型号 MAB4092 贝雷猫货号 RH169734 品牌 默克密理博/Millipore 单件重量 0kg 货期 15天 单位: 盒 包装: 盒 库存: 0 数量: 盒 + - 1盒起订,增量1盒 加入购物车立即购买 ...
P选择素糖蛋白配体1抗体,Anti-PSGL-1抗体规律 (1)初次反应产生抗体:当抗原次进入机体时,需经一定的潜伏期才能产生抗体,且抗体产生的量也不多,在体内维持的时间也较短。 (2)再次反应产生抗体:当相同抗原第二次进入机体后,开始时,由于原有抗体中的一部分与再次进入的抗原结合,可使原有抗体量略为降低。随后,抗体...
Anti-CD162 Antibody;Anti-Psgl-1 Antibody;Anti-Psgl1 Antibody;Anti-Selp1 Antibody;Anti-Selpl Antibody PSGL-1 / CD162 Background Information P-selectin glycoprotein ligand-1 (PSGL-1), also known as SELPLG or CD162, is the high affinitycounter-receptor for P-selectin on expressed on activated...
A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. Eur. J. Immunol. 35: 2239 -2249.Huang CC, Lu YF, Wen SN, et al. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. Eur. J. Immunol. 2005; 35 (7):2239–2249. [ PubMed ]...
Finally, soluble Siglec-5 interferes with interactions between PSGL1 and P-selectin in vitro, and displays strong anti-inflammatory activity in vivo. When analyzing PBMCs, we observed that about 50% of the cells express both Siglec-5 and PSGL1. This 50% corresponds to the potential Siglec-5...
United States Patent US9631019 Note: If you have problems viewing the PDF, please make sure you have the latest version of Adobe Acrobat. Back to full textHome Search Services Contact us © 2004-2024 FreePatentsOnline.com. All rights reserved. Privacy Policy & Terms of Use....